A. Kirschning, M. Mauduit et al.
was obtained (yield: 85%). 1H NMR (400 MHz, CDCl3, E/Z mixture
25:75): d=8.67 (br s, 1H; Z), 8.63 (br s, 1H; E), 8.53 (d, J=6.4 Hz, 2H;
E), 8.46 (d, J=5.9 Hz, 2H; Z), 8.19 (dd, J=7.9, 7.0 Hz, 1H), 7.71 (dd,
J=7.3, 6.8 Hz, 2H), 7.59 (d, J=7.7 Hz, 2H), 7.45 (d, J=2.0 Hz, 1H), 7.31
(d, J=8.1 Hz, 1H), 7.21 (s, 1H), 6.65 (d, J=9.5 Hz, 1H; Z), 6.60 (d, J=
8.6 Hz, 1H; E), 6.47 (dd, J=15.8, 2.2 Hz, 1H; E); 6.32 (dd, J=11.4, 1.8,
1H; Z), 6.01 (dq, J=15.8, 6.6 Hz, 1H; E), 5.61 (dq, J=11.4, 6.4 Hz, 1H;
Z), 5.56 (s, 1H), 4.28 (sept, J=6.2 Hz, 1H), 1.68–1.61 (m, 3H), 1.59 (s,
2H), 1.15 ppm (d, J=6.2 Hz, 6H); 19F NMR (376 MHz, CDCl3): d=
À70.9 ppm (d, J=718 Hz, 6F); 31P NMR (162 MHz, CDCl3): d=
À144.4 ppm (sept, J=718 Hz, 1P); 13C NMR (101 MHz, CDCl3, E/Z mix-
ture): d=167.61, 154.03, 147.56, 146.18, 137.93, 137.78, 134.63, 132.04,
130.20, 129.88, 129.81, 129.57, 129.27, 127.45, 126.59, 124.83, 122.25,
115.80, 72.34, 65.17, 29.37, 27.99, 22.46, 14.95, 14.03 ppm.
CDCl3, E/Z mixture): d=162.27, 141.48, 140.80, 133.27, 133.12, 126.63,
126.39, 126.15, 125.85, 125.42, 124.84, 120.55, 119.88, 119.86, 116.11,
113.94, 113.64, 75.37, 45.13, 25.97, 25.93, 18.98, 14.89, 9.85, 9.78 ppm;
HRMS: calcd for C13H18NO: 204.1388 [M+H]+; found: 204.1386.
General procedure for synthesis of oxazine ligand 19: An appropriate
halogen compound (1.2 equiv) was added to a mixture of NaH (4 equiv)
and the oxazine in THF (1 mL per 0.1 mmol of oxazinone) at 08C and
the mixture was stirred at RT for 3 h. THF was removed under reduce
pressure and EtOAc was added. The organic layer was washed with satu-
rated solutions of NaHCO3 and brine, dried over MgSO4, and evaporated
to dryness. The products were purified by column chromatography on
silica gel (cyclohexane/EtOAc, 9:1).
2-Ethyl-4-methyl-8-(prop-1-enyl)-3,4-dihydro-2H-benzo[b]ACTHNUGRTNEUNG[1,4]oxazine
(19a): Following the general procedure for the synthesis of the oxazine
ligand with methyl iodide (287 mL, 4.6 mmol, 10 equiv), NaH (74 mg,
1.28 mmol, 4 equiv), and compound 15a (100 mg, 0.46 mmol), the expect-
ed compound was isolated as a white solid as a mixture of E/Z isomers
(20:80, 75 mg, yield: 71%). 1H NMR (400 MHz, CDCl3, E/Z mixture):
d=6.71 (t, J=8.1 Hz, 1H), 6.68–6.64 (m, 1H; E), 6.61 (dd, J=7.5,
1.3 Hz, 1H; Z), 6.59–6.53 (m, 1H; E), 6.50 (dd, J=7.9, 1.3 Hz, 1H; Z),
6.48–6.42 (m, 1H), 6.12 (dq, J=15.8, 6.6 Hz, 1H; E), 5.70 (dq, J=11.4,
7.0 Hz, 1H; Z), 4.06–3.98 (m, 1H), 3.11 (dd, J=11.4, 2.4 Hz, 1H), 2.91
(dd, J=11.4, 7.9 Hz, 1H), 2.79 (s, 3H), 1.80 (dd, J=6.6, 1.8 Hz, 1H; E),
1.77 (dd, J=7.0, 1.8 Hz, 1H; Z), 1.73–1.47 (m, 2H), 1.00 (t, J=7.3 Hz
3H; E), 0.97 ppm (t, J=7.4 Hz 3H; Z); 13C NMR (101 MHz, CDCl3, E/Z
mixture): d=136.14, 126.37, 125.86, 125.68, 125.30, 120.61, 119.90, 119.34,
115.46, 110.90, 110.61, 74.92, 53.55, 39.08, 26.11, 14.90, 9.85, 9.79 ppm;
HRMS: m/z calcd for C14H20NO: 218.1545 [M+H]+; found: 218.1540.
8-Bromo-2-ethyl-2H-benzo[b]ACTHNUGRTENUNG[1,4]oxazin-3(4H)-one (16a): To a stirring
solution of 2-bromo butyric acid (10.0 mL, 0.0936 mole) in dry CH2Cl2
(100 mL) under a nitrogen atmosphere at 08C was added dropwise oxalyl
chloride (8.16 mL, 0.0936 mole) and 2 drops of DMF. The reaction mix-
ture was stirred at RT for 2 h. Then, the volatile compounds were con-
centrated under vacuum to give the crude material, which was dissolved
in CH2Cl2 (75 mL). This solution of acid chloride 18a was slowly added
to a mixture of amine 17a (16 g, 0.0851 mole) and pyridine (6.8 mL,
0.085 mole) at 08C over a period of 30 min. The reaction mixture was
stirred at RT for 2 h and then diluted with CH2Cl2. The organic layer was
washed with water, dried with anhydrous Na2SO4, and concentrated
under reduced pressure to afford a brown-colored semi-solid that was
used in the next step without further purification (28.0 g, yield: 98%).
The brown-colored semi-solid (34.0 g, 0.1008 mole) and K2CO3 (28.54 g,
0.2068 mole) were heated at reflux in DMF (800 mL) for 3 h. After the
completion of the reaction, the mixture was cooled to RT and poured
into a mixture of water and EtOAc. The organic layer was washed with
brine, dried over Na2SO4, and concentrated under reduced pressure to
give a crude residue that was purified by column chromatography on
silica gel (EtOAc/n-hexane, 15%) to obtain a pale-orange-colored solid
(14a, 21.0 g, yield: 79%). 1H NMR (400 MHz, CDCl3): d=7.84 (s, 1H),
7.14 (dd, J=8.1, 1.4 Hz, 1H), 6.76 (dd, J=8.1, 7.9 Hz, 1H), 6.65 (dd, J=
7.9, 1.4 Hz, 1H), 4.54 (dd, J=9.1, 4.2 Hz, 1H), 2.00–1.71 (m, 2H),
1.08 ppm (t, J=7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3): d=167.20,
139.69, 127.75, 127.27, 123.17, 114.43, 111.37, 79.04, 23.95, 9.61 ppm.
Isobutyl-2-ethyl-8-(prop-1-enyl)-2H-benzo[b]ACTHNUTRGNE[UNG 1,4]oxazine-4(3H)-carboxy-
late (19b): Following the general procedure for the synthesis of the oxa-
zine ligand with isobutyl chloroformate (392 mL, 3 mmol, 2.5 equiv), NaH
(192 mg, 4.8 mmol, 4 equiv), and compound 15a (261 mg, 1.2 mmol), the
expected compound was isolated as a white solid as a mixture of E/Z iso-
mers (60:40, 380 mg, yield: 99%); 1H NMR (400 MHz, CDCl3, E/Z mix-
ture): d=7.67–7.49 (m, 1H), 7.06 (dd, J=7.7, 1.3 Hz, 1H; E), 6.94 (dd,
J=7.5, 1.5 Hz, 1H; Z), 6.83–6.69 (m, 1H), 6.61 (dd, J=15.6, 1.8 Hz, 1H;
E), 6.43 (dd, J=11.4, 1.8 Hz, 1H; Z), 6.15 (dq, J=15.6, 6.8 Hz, 1H; E),
5.74 (dq, J=11.4, 7.3 Hz, 1H; Z), 4.19–3.97 (m, 2H), 3.97–3.86 (m, 2H),
3.29–3.16 (m, 1H), 2.00–1.88 (m, 1H), 1.82 (dd, J=6.6, 1.8 Hz, 3H; E),
1.77 (dd, J=7.0, 1.8 Hz, 3H; Z), 1.72–1.54 (m, 2H), 1.02 (t, J=7.7 Hz,
3H; E), 0.99 (t, J=7.7 Hz, 3H; Z), 0.90 (d, J=6.8 Hz, 6H; E) 0.88 ppm
(d, J=6.6 Hz, 6H; Z); 13C NMR (101 MHz, CDCl3, E/Z mixture): d=
154.07, 143.8, 143.1, 126.9, 126.6, 126.6, 125.9, 125.6, 125.5, 125.5, 125.3,
124.8, 121.7, 119.5, 118.9, 76.2, 72.4, 45.8, 30.3, 29.7, 27.9, 26.9, 25.7, 25.6,
22.7, 19.2, 19.2, 18.9, 14.8, 9.6, 9.5 ppm; HRMS: m/z calcd for
C18H25NO3Na: 326.1732 [M+Na]+; found: 326.1762.
2-Ethyl-8-(prop-1-enyl)-3,4-dihydro-2H-benzo[b]ACHTNUTRGNE[NUG 1,4]oxazine (15a): To a
stirring solution of tetrakis(triphenylphosphine)palladium(0) (6.16 g,
5.32 mmol) in toluene (150 mL) was added a solution of compound 16a
(21.0 g, 0.0819 mol) in toluene (100 mL). The mixture was degassed for
15 min, then propenyltri-n-butyltin (44.36 g, 0.1352 mol) was added and
the mixture was stirred at 1108C for 12 h under a nitrogen atmosphere.
After filtration through a bed of celite followed by column chromatogra-
phy on silica gel (EtOAc/n-hexane, 15%), the expected 2-ethyl-8-(prop-
1-enyl)-2H-benzo[b][1,4]oxazin-3(4H)-one (14.7 g) was obtained (yield:
84%) as pale-orange solid. 1H NMR (400 MHz, CDCl3, E isomer): d=
7.65 (s, 1H), 7.04 (dd, J=7.9, 1.3 Hz, 1H), 6.83 (dd, J=7.9, 7.7 Hz, 1H),
6.59 (dq, J=15.9, 1.7 Hz, 1H), 6.53 (dd, J=7.7, 1.3 Hz, 1H), 6.26 (dq, J=
15.9, 6.7 Hz, 1H), 4.45 (dd, J=8.7, 4.3 Hz, 1H), 1.97–1.71 (m, 5H),
0.85 ppm (t, J=7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): d=168.67,
140.26, 128.31, 126.71, 124.29, 123.63, 121.53, 114.37, 78.22, 23.85, 18.97,
14.80, 9.82 ppm.
(2-Ethyl-8-(prop-1-enyl)-2H-benzo[b]
ACHTUNGERTN[NUNG 1,4]oxazin-4(3H)-yl)-
AHCTUNGTRENNUNG
thesis of oxazine ligand with benzoyl chloride (348 mL, 3 mmol,
2.5 equiv), NaH (192 mg, 4.8 mmol, 4 equiv), and compound 15a
(261 mg, 1.2 mmol), the expected compound was isolated as a white solid
as a mixture of E/Z isomers (65:35, 300 mg, yield: 78%); 1H NMR
(400 MHz, CDCl3): d=7.46–7.38 (m, 2H), 7.38–7.31 (m, 1H), 7.31–7.22
(m, 2H), 7.03 (dd, J=7.7, 1.1 Hz, 1H; E), 6.93 (dd, J=7.7, 1.1 Hz, 1H;
Z), 6.70–6.39 (m, 3H), 6.23 (dq, J=16.1, 6.4 Hz, 1H; E), 5.78 (dq, J=
11.4, 7.4 Hz, 1H; Z), 4.28–4.12 (m, 2H), 3.38 (dd, J=7.7, 6.1 Hz, 1H),
1.84 (dd, J=6.6, 1.5 Hz, 3H; E), 1.78 (dd, J=7.0, 2.0 Hz, 3H; Z), 1.76–
1.53 (m, 2H), 1.01 ppm (t, J=7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3,
E/Z mixture): d=168.90, 143.35, 135.43, 135.30, 130.64, 130.67, 128.62,
128.66, 128.45, 128.33, 127.34, 127.14, 126.81, 126.38, 126.27, 125.03,
124.58, 123.07, 122.92, 122.67, 119.18, 118.53, 25.95, 18.98, 14.88, 9.67,
9.52 ppm; HRMS: m/z calcd for C20H21NO2Na: 310.1470 [M+Na]+;
found: 330.1458.
Next, the previously prepared 2-ethyl-8-(prop-1-enyl)-2H-benzo[b]-
ACHTUNGTRENNUNG[1,4]oxazin-3(4H)-one (1.2 g, 5.5 mmol) was added to a suspension of
LAH (418 mg, 2 equiv, 11 mmol) in THF (50 mL) at 08C. The resulting
suspension was stirred at RT for 1 h. Water and a 1m solution of NaOH
were slowly added at 08C. The resulting precipitate was filtered through
a bed of celite and washed with warm THF. After concentration under
vacuum, compound 15a (1.1 g) was obtained as a mixture of E/Z isomers
(60:40, yield: 99%) without further purification. 1H NMR (400 MHz,
CDCl3): d=6.75–6.34 (m, 4H), 6.16 (dq, J=15.8, 6.6 Hz, 1H; E), 5.72
(dq, J=11.4, 7.0 Hz, 1H; Z), 3.98–3.91 (m, 1H), 3.28 (ddd, J=11.4, 2.9,
2.9 Hz, 1H), 3.04 (ddd, J=11.4, 7.7, 1.1 Hz, 1H), 1.81 (dd, J=6.6, 1.5 Hz,
3H; E), 1.77 (dd, J=7.0, 1.8 Hz, 3H; Z), 1.75–1.49 (m, 2H), 1.01 (t, J=
7.5 Hz, 3H; E), 0.98 ppm (t, J=7.5 Hz, 3H; Z); 13C NMR (101 MHz,
(2-Ethyl-8-(prop-1-enyl)-2H-benzo[b]ACTHNUGTRNEUNG[1,4]oxazin-4(3H)-yl)(perfluoro-
phenyl)methanone (19d): Following the general procedure for the syn-
thesis of the oxazine ligand with pentafluorobenzoyl chloride (141 mL,
0.98 mmol, 2 equiv), NaH (78 mg, 1.96 mmol, 4 equiv), and compound
15a (100 mg, 0.49 mmol), the expected compound was isolated as a white
16378
ꢄ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2012, 18, 16369 – 16382